Articles From: Retirement Plan Landscape Stabilizing as Fewer Fortune 500 Companies Shifting Defined Benefit Plans to 401(k)s, Towers Watson Analysis Finds to Revolution Lighting Technologies Enters into Loan and Security Agreement with Bank of America


2014/9/4
The retirement plan landscape is stabilizing as fewer U.S. companies last year moved from defined benefit (DB) plans to offering only a defined contribution (DC) plan to new salaried employees than in any other year over the past decade, according to a new analysis by global professional services company Towers Watson (NYSE, NASDAQ: TW). The analysis also found that a few industry sectors — insurance and utilities — are bucking the trend from DB to DC plans.
Sign-up for Retirement Plan Landscape Stabilizing as Fewer Fortune 500 Companies Shifting Defined Benefit Plans to 401(k)s, Towers Watson Analysis Finds investment picks
Americans who have access to 401(k) plans can help to achieve a more secure retirement if they start early and save consistently over the course of their career, according to new research sponsored by Prudential Financial, Inc. (NYSE:PRU). The findings of the latest National Retirement Risk Index (NRRI) , published by The Center for Retirement Research (CRR) at Boston College, are encouraging.
Sign-up for Retirement readiness within reach for Americans who take advantage of 401(k) plans investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0962130003&sourceType=1 http://www.ccnmatthews.com/logos/20110201-biron200.jpg TORONTO, ONTARIO --
Sign-up for RETRANSMISSION: Black Iron's Shymanivske Project Awarded Mining Allotment From Ukraine Government investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0955396001&sourceType=1 http://media3.marketwire.com/logos/20130113-cgi_logo_b.jpg FAIRFAX, VIRGINIA --
Sign-up for RETRANSMISSION: CGI Awarded $89 Million Contract for State of Michigan ERP Modernization Project investment picks
Retrophin, Inc. (NASDAQ:RTRX) today announced that it has closed a $45 million senior secured term loan facility, led by funds advised by Athyrium Capital Management.
Sign-up for Retrophin Closes $91 Million Financing investment picks
Retrophin, Inc. (NASDAQ:RTRX) today reported its financial results for the quarter ended June 30, 2014.
Sign-up for Retrophin Reports Second Quarter 2014 Financial Results investment picks
Retrophin, Inc. (NASDAQ:RTRX) announced today that it will report its second quarter 2014 financial results on Tuesday, August 12, 2014.
Sign-up for Retrophin to Report Second Quarter 2014 Financial Results investment picks
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG) today announced that a retrospective analysis of MM-003, the Company’s phase III study of pomalidomide plus low-dose dexamethasone compared with high-dose dexamethasone in patients with refractory multiple myeloma who have failed therapy with both bortezomib and lenalidomide, administered either alone or in combination, were presented at the 19th European Hematology Association annual congress.
Sign-up for Retrospective Analysis of Overall Survival Adjusting for Patient Crossover in Phase III Study of POMALYST®/IMNOVID® (Pomalidomide) in Previously Treated Multiple Myeloma Presented at EHA investment picks
2014/7/5
Hosted by actor/television host Terrence 'J' Jenkins and actress Tika Sumpter, the star-studded event included musical tributes by recording artists Ledisi, Kim Burrell, Tank and Jasmine Sullivan NEW ORLEANS , July 5, 2014 /PRNewswire/ -- Notable community leaders, celebrities and entertainers were out in full force at this year's McDonald's 365Black Awards, held today at the New Orleans Theater in the Ernest N.
Sign-up for Rev. Al Sharpton, Will Packer, Iyanla Vanzant, Among Those Honored at 11th Annual McDonald's 365Black Awards in New Orleans investment picks
2014/8/20
Hyatt Hotels Corporation (NYSE: H) today announced a new feature on Hyatt’s revamped iOS and Android app that makes it easier for guests to get from their current location to their Hyatt hotel.
Sign-up for Revamped Hyatt Mobile App Now Includes Integration with Uber investment picks
NEWARK, Calif., June 24, 2014 (GLOBE NEWSWIRE) -- Revance Therapeutics, Inc. (Nasdaq:RVNC) , a biopharmaceutical company developing botulinum toxin products for use in aesthetic and therapeutic indications, announced today the closing of its follow-on public offering of 4,600,000 shares of common stock at a public offering price of $30.50 per share.
Sign-up for Revance Therapeutics Announces Closing of Its Follow-on Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares investment picks
NEWARK, Calif., Sept.
Sign-up for Revance Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) investment picks
NEWARK, Calif., June 18, 2014 (GLOBE NEWSWIRE) -- Revance Therapeutics, Inc. (Nasdaq:RVNC) today announced the pricing of its underwritten public offering of 4,000,000 shares of its common stock at a price to the public of $30.50 per share pursuant to a registration statement filed with the Securities and Exchange Commission (SEC). All of the shares in the offering are to be sold by Revance.
Sign-up for Revance Therapeutics Announces Pricing of Its Public Offering of Common Stock investment picks
NEWARK, Calif., June 16, 2014 (GLOBE NEWSWIRE) -- Revance Therapeutics, Inc. (Nasdaq:RVNC) today announced a proposed underwritten public offering of 3,000,000 shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission (SEC). Revance expects to grant the underwriters a 30-day option to acquire an additional 450,000 shares.
Sign-up for Revance Therapeutics Announces Proposed Public Offering of Common Stock investment picks
NEWARK, Calif., Aug.
Sign-up for Revance Therapeutics Releases Second Quarter 2014 Financial Results investment picks
NEWARK, Calif., July 29, 2014 (GLOBE NEWSWIRE) -- Revance Therapeutics, Inc. (Nasdaq:RVNC) , a biopharmaceutical company developing botulinum toxin products for use in aesthetic and therapeutic indications, announced today that the Company will release second quarter 2014 financial results on Tuesday, August 12, 2014 after the close of market.
Sign-up for Revance Therapeutics to Release Second Quarter 2014 Financial Results and Host Conference Call on Tuesday, August 12, 2014 investment picks
LA JOLLA, Calif.
Sign-up for Reven Housing REIT Acquires Portfolio in Jacksonville, Florida investment picks
LA JOLLA, Calif.
Sign-up for Reven Housing REIT Acquires Portfolios in Memphis, Tennessee investment picks
2014/8/11
Los Angeles Tribune profiles several innovative systems manufactured by AVT CORONA, Calif.
Sign-up for Revenue in American Vending industry Projected to Rise and Hit $7.7 billion in 2019 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0964478001&sourceType=1 http://media3.marketwire.com/logos/20140326-rvm_logo.png SPOKANE VALLEY, WASHINGTON --
Sign-up for Revett Announces US $5 Million Loan Agreement investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961949001&sourceType=1 http://media3.marketwire.com/logos/20140326-rvm_logo.png SPOKANE VALLEY, WASHINGTON --
Sign-up for Revett Reports Q2 2014 Financial Results and provides Troy Mine Development Update investment picks
2014/8/25
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1139995&ProfileId=051205&sourceType=1 SILVERADO, CA --
Sign-up for REVI Continues Development of "WikiClickPrint.com" investment picks
CLEVELAND, July 21, 2014 (GLOBE NEWSWIRE) -- TFS Financial Corporation (Nasdaq:TFSL) (the "Company"), the holding company for Third Federal Savings and Loan Association of Cleveland, will report its financial results for three and nine month periods ending June 30, 2014, on Wednesday, July 30, 2014, after 4:00 p.m. Eastern Time.
Sign-up for Revised Conference Call Time - 3 p.m. Eastern Time, July 31 for TFS Financial Corporation Fiscal Quarter Ended June 30, 2014 Financial Results investment picks
2014/9/3
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION NORTH CHICAGO, Ill.
Sign-up for Revised GAAP earnings guidance for AbbVie Inc for the Financial Year ending December 31, 2014 and Third Quarter ending September 30, 2014; Confirms Adjusted Earnings Guidance investment picks
KMG Chemicals, Inc. (NYSE: KMG), a global provider of specialty chemicals in select markets, today announced a revision to the previously announced shareholder record date for the quarterly cash dividend on its common stock.
Sign-up for Revision of Shareholder Record Date for Quarterly Dividend investment picks
Revlon, Inc. (NYSE:REV) today announced results for the second quarter ended June 30, 2014.
Sign-up for Revlon Reports Second Quarter 2014 Results investment picks
Revlon, Inc. (NYSE:REV) today announced that on Wednesday, July 30, 2014, the Company intends to release results for the second quarter ended June 30, 2014 and host a conference call at 9:30 AM EDT.
Sign-up for Revlon to Release Second Quarter 2014 Results and Host a Conference Call on July 30, 2014 investment picks
Revolution Lighting Technologies, Inc. (NASDAQ:RVLT) (“Revolution Lighting”), a leader in advanced LED lighting solutions, today announced that it will release financial results for the second quarter of 2014 prior to market open on August 7, 2014.
Sign-up for Revolution Lighting Technologies Announces Reporting Date for Second Quarter of 2014 investment picks
Revolution Lighting Technologies, Inc. (NASDAQ:RVLT) (“Revolution Lighting”), a leader in advanced LED lighting solutions, today announced that it has entered into a three year loan and security agreement with Bank of America.
Sign-up for Revolution Lighting Technologies Enters into Loan and Security Agreement with Bank of America investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Retirement Plan Landscape Stabilizing as Fewer Fortune 500 Companies Shifting Defined Benefit Plans to 401(k)s, Towers Watson Analysis Finds to Revolution Lighting Technologies Enters into Loan and Security Agreement with Bank of America
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices